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Background: Cystic fibrosis is a disease where mutations in the cftr gene lead to loss of a chloride channel.
Results: The CFTR transmembrane domains show an outward facing configuration.
Conclusion: The map shows regions that probably represent the channel’s gate and its regulatory region.
Significance: Residues associated with changes in channel function and disease are adjacent to the gate.
Cystic fibrosisaffectsabout1 in2500 livebirthsand involves loss
of transmembrane chloride flux due to a lack of a membrane pro-
tein channel termed the cystic fibrosis transmembrane conduct-
ance regulator (CFTR). We have studied CFTR structure by elec-
tron crystallography. The data were compared with existing
structuresofotherATP-bindingcassette transporters.Theprotein
was crystallized in the outward facing state and resembled thewell
characterized Sav1866 transporter. We identified regions in the
CFTR map, not accounted for by Sav1866, which were potential
locations for the regulatory region as well as the channel gate. In
this analysis, we were aided by the fact that the unit cell was com-
posed of two molecules not related by crystallographic symmetry.
We also identified regions in the fitted Sav1866 model that were
missing fromthemap,hence regions thatwereeitherdisordered in
CFTRordifferentlyorganizedcomparedwithSav1866.Apart from
the N and C termini, this indicated that in CFTR, the cytoplasmic
end of transmembrane helix 5/11 and its associated loop could be
partly disordered (or alternatively located).
Cystic fibrosis is one of themost common inherited diseases,
with roughly 1 in 22 carriers in the Caucasian population and
with an incidence of about 1 in 2500 live births. The primary
defect is loss of function of a plasma membrane-located chlo-
ride channel termed the cystic fibrosis transmembrane con-
ductance regulator (CFTR)2 (1–3). Carriers and most affected
individuals have at least one copy of a mutated form of the cftr
gene, which leads to a deletion of phenylalanine at position 508
in the human CFTR protein sequence (2, 3). This deletion
(F508del) causes misfolding of the protein, retention in the
endoplasmic reticulum, and its premature degradation in the
cell; hence, very little protein reaches the plasmamembrane (1).
To some extent, wild-type CFTR protein shows a similar tend-
ency, with a significant proportion failing to get to the plasma
membrane. The Phe-508 deletion also impairs the channel
function of the small fraction of the protein that reaches the
plasmamembrane (1).Many othermutations in theCFTR gene
or protein have been identified (4), but these are relatively rare
and almost always occur with the F508del mutation on the sec-
ond copy of the gene.
The CFTR protein is part of a larger family of interrelated
membrane proteins called the ATP-binding cassette (ABC)
transporters (5). In these transporters, ATP binding at the well
conserved cytoplasmic domains is thought to drive a change
from an inward to outward facing configuration in the mem-
brane-spanning domains of the protein (5). This motion is
thought to produce the net translocation of substances across
the membrane against a concentration gradient (5). However,
CFTR is unique in this family by having a channel activity (1,6),
where substances passing through the protein (preferentially
chloride ions in this case)move passively down a concentration
gradient (1, 6). In CFTR, bound ATP stabilizes the open chan-
nel state rather than driving transport (1, 6). Divergence of
CFTR from the ABC transporter family appears to have
occurred relatively recently, appearing in salt-transporting tis-
sues of marine and terrestrial higher organisms, and it is char-
acterized by a unique insertion in the middle of the CFTR pro-
tein of about 210 amino acid residues that performs a
regulatory function in CFTR (1, 7). Phosphorylation of serine
and threonine residues in this region results in the activation of
the CFTR channel (1, 6), which can thereafter be opened by
ATP (1, 6, 7). Relatively little is known about the structure of the
regulatory region, although it has been predicted to be mostly
disordered, a hypothesis that is consistent with NMR data for
the separately expressed and purified regulatory region peptide
(7). However, low resolution electronmicroscopy data coupled
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to labeling of the regulatory region with 1.8-nm gold spheres
has identified a relatively well defined location for some of its
residues when it is part of the full-length CFTR protein (8, 9).
Similarly, NMR data shows some interaction of the isolated
regulatory region with isolated CFTR nucleotide-binding
domains when mixed together in vitro (7).
Hypotheses for the evolution of channel function of CFTR
can be proposed, which suggest that the outward facing, ATP-
bound, state of ABC transporters is likely to be the conforma-
tion adopted by CFTR when the channel is actively gating,
whereas the inward facing transmembrane configuration is
consistent with an inactive state (5, 6, 10). These assumptions
fit with the observations that ATP is required for channel activ-
itywhen theCFTRchannel is studied (e.g.by patch clampmeas-
urements) in situ and with single-channel recording measure-
ments on black lipid membranes with which CFTR-containing
vesicles have been fused (5, 6, 10–13). Similarly, long quiescent
periods of the channel are consistent with the expected turn-
over of ATP by CFTR nucleotide-binding domain 2 (5, 6,
10–13). Prevention of ATP hydrolysis at NBD2 greatly pro-
longs channel open time.However, channel recordings can also
show very rapid “flickering” transitions from open to closed
states or to subconductance states on a time scale greatly incon-
sistent with the rate of ATP hydrolysis by CFTR (14, 15). These
data imply rapid, presumably small, conformational shifts that
can give rise to transient closing (or partial closing) and reopen-
ing of the channel when in the ATP-bound state. Examination
of the structural changes between inward and outward facing
conformations of ABC transporters highlights the major rear-
rangements of both cytoplasmic and transmembrane portions
of the protein that must occur (5, 16, 17). Such large conforma-
tional shifts appear to be consistent with the moderate ATP
turnover rate of these proteins (e.g. 2 s1 for ABCB1, a eukary-
otic multidrug transporter (18, 19)) but inconsistent with the
rapid switch between conductance states in the CFTR channel.
In addition, there are a number of conditions under which the
same open channel state can be reached in either the presence
or absence of the ATP ligand (20). Thus, there does not appear
to be an obligatory direct mechanical coupling between the
bound ATP/outward facing state and the channel open state.
There are still significant gaps in our knowledge that is derived
from the structural data base for ABC transporters, gaps that
result from the difficulty of crystallization of membrane pro-
teins, especially in alternative conformational states. To date,
there are a fewABC transporters forwhich structural data show
a large conformational shift between inward and outward fac-
ing states (21–24). Other structural data for ABC transporters,
in contrast, can be interpreted as implying only minor confor-
mational changes upon ATP binding or hydrolysis (25–30). An
alternative hypothesis could therefore be promulgated, where
flux of anions throughCFTR requiresminor rearrangements in
a channel gate region and with minimal structural changes
associated with the binding of ATP.
In order to know more about the properties of CFTR and its
unique regulatory region and to test the various hypotheses
concerning structure-function and channel gating, structural
data for CFTR are desirable. Previously, we produced two-di-
mensional crystals of CFTR in the presence of the non-hydro-
lyzable ATP analog AMP-PNP (31). These crystals were nega-
tively stained with uranyl acetate and imaged by conventional
electron microscopy; hence, the resolution was limited (32). In
contrast, the CFTR crystals we have studied here were in the
frozen-hydrated state in the absence of a heavy atom stain, pro-
viding higher resolution than with negative staining, with the
proviso that large and well ordered two-dimensional crystals
must be obtained to overcome the signal/noise limitations of
the images (32). We were able to identify conditions that
yielded better ordered, larger, and more reproducible two-di-
mensional arrays of the protein. These conditions were
obtained in the absence of nucleotide from the crystallization
droplet. Moreover, under these conditions, the protein is orga-
nized in two crystalline layers stacked on top of each other. The
purified protein has previously been shown to be glycosylated
andmostly dephosphorylated (9). The latter characteristic sug-
gests that the protein was in the quiescent, closed channel state
and, without ATP, would be predicted to be in an inward facing
conformation (23, 24, 33) .
EXPERIMENTAL PROCEDURES
Protein—Full-length humanCFTRwith a decahistidine puri-
fication tag at the C terminus was expressed in BHK cells as
described previously (31). Membrane solubilization and subse-
quent CFTR purificationwas carried out in the detergent dode-
cyl maltoside using two affinity chromatography steps, as
described before (31). The glycosylation and phosphorylation
states of the protein expressed and purified in thismanner have
been described (9); the protein appears to be fully glycosylated
but mostly dephosphorylated.
Crystallization—Crystallization trials were set up as
described before (31) at 4 °C, using the sitting droplet method,
with 400-mesh/inch carbon-coated gold grids (TAAB Labora-
tories Equipment Ltd.) placed on the surface of the droplet. The
droplets were then left overnight with concentration of solutes
in the droplet via the vapor phase against a 1 MMgCl2 solution.
Droplets contained protein at a concentration of 50 g/ml in
0.05% dodecyl maltoside, polyethylene glycol 4000 (10%, w/v),
100 mM ammonium sulfate, and 50 mM Tris-HCl, pH 8.0.
Batches of purified protein were screened for the presence and
quality of two-dimensional crystals by negative staining with
4% (w/v) uranyl acetate. For cryo-EM, grids were carefully
removed from the droplets, blotted, and immediately frozen in
liquid ethane using a FEI Vitrobot freezing system.
Electron Microscopy—Images were recorded on a Polara
300-kV Field Emission Gun transmission electron microscope
(University of Manchester) or a CM20 200-kV Field Emission
Gun microscope (University of Leeds). In both cases, images
were recorded using a Gatan 4096  4096 pixel CCD camera,
with binning to 2048  2048 for the tomography experiments.
Crystallographic image processing was applied to the images,
using routines developed at theMedical Research Council Lab-
oratory of Molecular Biology and implemented within the 2dx
package. Structure factors were combined by phase origin
adjustment and refinement, and then lattice lines were interpo-
lated using the 2dxmerge package. The final three-dimensional
map was generated using standard CCP4 routines (34) without
the application of solvent flattening. Tomography data were
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recorded using FEI tomography control software, with tilting
between 65° and 65°, with 2.5° increments up to 50° and
then 1° increments up to 65°. The total electron dose was
restricted to 40 electrons/Å2. Subsequent processing was car-
ried out with the IMOD tomography package (35). No fiducial
gold markers were used. Tilted images were initially aligned
using cross-correlation, and then a manual refinement of the
alignment was performed using easily identifiable features as
fiducials. Mean residuals for the fiducial tracking were 3 pix-
els using the full 2048 2048 images. Further details onmicro-
scope and image processing parameters are provided inTable 1.
Interpretation—The three-dimensional map was displayed
using the Chimera software package (36). A low resolutionmap
was initially calculated at 1⁄18 Å1 resolution, allowing a prelim-
inary semiautomated fitting of model structures and an assess-
ment of the packing within the two-dimensional crystal. Fitting
was carried out by placing the models within the map by hand
and then refining using the Fit-in-Map Chimera routine with
optimization for correlation between the experimental CFTR
map and a simulatedmap based on the fitted model, which was
arbitrarily restricted to the same resolution as the experimental
map. A higher resolution map was then calculated at 1⁄9 Å1,
and the fitting of the models was repeated. This resolution was
taken as a compromise between the relatively higher in-plane
resolution (Table 1) and the lower resolution perpendicular to
the plane, which extended to 1⁄12 Å1 (supplemental Fig. 1).
Regions of the higher resolution map that were 1 or more
above the mean density were included in the correlation calcu-
lation. Several copies were placed in the upper and lower layers
of the map. Regions of the map 5 Å from any Sav1866 atom
were displayed using the Chimera Color Region and Split Map
functions, and the local map density was used to color Sav1866
residues with the Chimera Values at Atom Positions function.
RESULTS
Crystallization—The methodology for producing the CFTR
two-dimensional crystals involves adaptations of the sitting drop
approach commonly employed for generating three-dimensional
crystals of biomolecules (37). Not surprisingly, this method can
yield multilayered, thin three-dimensional crystals as well as the
desired two-dimensional crystals (37). A typical CFTR two-di-
mensional crystallization zone is indicated in Fig. 1a. The zone is
roughly 1m inwidth and follows the outline of the gridwindow.
A dense layer of increasing thickness is found closer to the grid
bars, andbare carbon is encounteredbeyond the two-dimensional
crystallization zone, toward the center of the window.
FIGURE 1. Tomography of CFTR two-dimensional crystals. a, micrograph
of a negatively stained CFTR two-dimensional crystallization zone (central
region) flanked by bare carbon toward the center of the grid window (top
right) and a thick zone (bottom left), where structure is less apparent. b, slice
perpendicular to the crystal plane and along one crystal axis taken from an
electron tomographic reconstruction of the two-dimensional crystal zone. c,
an unfiltered three-dimensional isosurface viewed along the crystal plane
shows a two-layered, 25-nm-thick profile. d, a projection equivalent to that
in c after Fourier filtration. e, a slice along the crystal plane, with individual
CFTR molecules packed in a crystalline array.
TABLE 1
Summary of electron crystallographic data for the CFTR two-dimensional crystals
Parameter Value
No . of crystal areas merged 121
Size of crystal areas (pixels) 4096  4096 or 2048  2048
Pixel size at the specimen level 1.9 Å (CCD) , 1.19 Å (film)
Unit cell parameters a 	 72.3 Å (S.D. 	 0.53 Å) (n 	 10)
b 	 75.8 Å (S.D. 	 0.58 Å) (n 	 10)
 	 124.0° (S.D. 	 0.67°) (n 	 10)
Two-sided space group P1
Range of crystal tilts 0–65°
Tilt range (number of crystals) 0–25° (30); 25–35° (15); 35–45° (21); 45–50° (18); 50–60° (26); 60–65° (11).
Range of underfocus 1000 to 30,000 Å
Total no. of measurements 13,694
Phase residual (untilted crystals)a
100.0–24.0 Å resolution 36.6°
24.0–12.0 Å resolution 42.9°
12.0–9.9 Å resolution 56.2°
9.9–7.0 Å resolution 51.8°
7.0–5.7 Å resolution 66.8°
5.7–4.9 Å resolution 76.2°
Data completeness to 1⁄6 Å1 in plane 91%
Overall weighted interimage phase residualb 32.1°
Overall weighted R-factor 37.5%.
a Where random data would give rise to a mean phase residual of 90°.
b For fitted lattice lines, including data to IQ 7 and to a nominal in-plane resolution of 1⁄6 Å1.
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Electron Tomography—We carried out electron tomography
(38) on negatively stained two-dimensional crystals within the
crystallization zone (Fig. 1, b–e). The overall thickness of the two-
dimensional crystals was found to be about 250 Å, and there was
no evidence for a tapering to a single molecular layer as the zone
extended out to the center of the window (Fig. 1b). The tomo-
grams indicated that the two-dimensional crystals were probably
composed of two 125-Å-thick layers of CFTR molecules, with
translational and rotational shifts between the two layers (Fig. 1, c
and d). Low resolution filtering and patch-averaging of slices per-
pendicular to the crystal plane confirmed their two-layerednature
(Fig. 1d). A slice along the crystal plane shows individual CFTR
molecules packed in a crystalline array (Fig. 1e).
Electron Crystallography—Unstained two-dimensional crys-
tals were imaged by cryoelectron microscopy processed using
electron crystallography software (39, 40). The three-dimen-
sional data are summarized in Table 1, and lattice lines, which
were calculated and then sampled at regular intervals, assuming
a crystal thickness of 250 Å, are shown in supplemental Fig. 1.
Examination of phase residuals after merging of the untilted
crystal data (Table 1) gave an indication of the maximal resolu-
tion of the data set (i.e. in the crystal plane); however, the overall
resolution of themerged three-dimensionalmap is anisotropic,
with lower resolution in the z* direction of reciprocal space.
This is due to the well knownmissing cone problem (41) and is
made worse by problems of adequately sampling reciprocal
space due to the large z-dimension of the unit cell and its low
symmetry (32). Data along lattice lines extend to about 1⁄12 Å1
(supplemental Fig. 1), whereas the in-plane resolution extends
to 1⁄7 Å1 (Table 1).
CFTR Three-dimensional Coulomb Density Map—An initial
map, restricted to a resolution of 1⁄18 Å1, was generated, as
displayed in Fig. 2. At this resolution, the molecular envelopes
of the CFTR molecules and their packing within the unit cell
FIGURE 2. CFTR map at low resolution. Left, CFTR map with a resolution
cut-off of 1⁄18 Å1, allowing the molecular envelope of the two CFTR mole-
cules in each unit cell to be clearly seen. Three adjacent unit cells and six CFTR
molecules are displayed. Right, interpretation of the packing in one unit cell,
using two bacterial Sav1866 transporters as models (blue mesh delineates the
molecular envelope; ribbon trace shows the secondary structure).
FIGURE 3. CFTR three-dimensional map displayed with a resolution cut-off of 1⁄9 Å1 and its interpretation. Shown are slices through the CFTR three-
dimensional density map (mesh) illustrating the fitting of several copies of the Sav1866 molecular model (colored ribbons). A region of the map 50 Å thick and
roughly 2 unit cells across is shown. The viewing direction is perpendicular to the crystallographic a axis (left) or b axis (right) and along the crystal ab plane.
Density within 5 Å of the fitted Sav1866 model atoms is colored according to the nearest fitted model. At a threshold of 1 above the mean density, virtually all
of the density in the unit cell is within 5 Å of the Sav1866 models. In the lower half of the map, a region occupied by the extracellular portions of a few of the TM
helices in the Sav1866 model is missing or displaced (red dashed outline).
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can be readily delineated. The expected packing and relative
orientation of the two CFTR molecules in each unit cell are
illustrated on the right in Fig. 2 using two Sav1866 (30) mole-
cules (Protein Data Bank entry 2HYD) as surrogates for CFTR.
Correlation coefficients of 0.7 were obtained for each
Sav1866model. The long axis of each fitted Sav1866model was
tilted relative to the crystal plane, by about 15° for the lower
layer and by about 32° for the upper layer. Molecules in the
two layers were related to each other by a rotation of about 130°
around the normal to the crystal plane and 40° and 30° rotations
about the a and b crystallographic axes, respectively (finally
coupled to a 110-Å vertical translation). Contacts appear to be
formed between the extracellular loop regions of the upper
layer and the NBDs of the lower layer of CFTR molecules.
Fig. 3 displays the three-dimensional density map with reso-
lution restricted to 1⁄9 Å1 superimposed with several fitted
copies of the Sav1866 model. A more complete description of
this higher resolution map is presented in supplemental Fig. 2
using serial 10-Å-thick slices taken parallel to the ab crystal
plane. The overall fitting of two copies of the outward facing
Sav1866 model to the CFTR map was significantly better than
for two copies of an inward facing model (ABCB1, P-glycopro-
tein 3G5U (24)). First, correlation coefficients were 0.513 and
0.499 for the fitting of Sav1866 to the upper and lower layers of
FIGURE 4. Additional density in the CFTR map. Shown is density (white mesh) that is 5 Å from the nearest atoms of the fitted Sav1866 models in the upper
layer (yellow model; a, c, and e) and the lower layer (blue model; b, d, and f). a– d, a lozenge-shaped region of density predicted to be in the center of the
transmembrane domains. Sav1866 TM helices are numbered in a. The panels display slices 10-Å-thick along (a and b) and perpendicular (c and d) to the long
axes of the fitted Sav1866 models. e and f, an extended region of density is observed that wraps around the surface of the NBDs of the fitted models. The nearest
surface residues in the Sav1866 model are displayed.
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the map, respectively. In contrast, P-glycoprotein fitted with
corresponding values of 0.482 and 0.371. Second, the Sav1866
fitting produced matches with no clash between adjacent unit
cells or between upper and lower layers of the map. For P-gly-
coprotein, the correlation-optimized fits led to significant over-
lap into adjacent unit cells, clearly inconsistent with the unit
cell parameters. The transmembrane domains (TMDs) of the
molecule in the lower layer make contact with the (hydropho-
bic) carbon support film and appear to be somewhat distorted
by this contact (Fig. 3, red outline). Coulomb density is weaker
in this region and displaced versus the expected position of the
extracellular regions of the fitted Sav1866 model (30).
DISCUSSION
Outward Facing Conformation—An outward facing confor-
mation of CFTR is somewhat surprising, given that it was crys-
tallized in the absence of nucleotide and phosphorylation.
However, structural data allow for intermediate conformations
of ABC transporters. For example, an inward facing state with a
full complement of bound nucleotide was described recently
(42), whereas an outward facing conformationwas observed for
Sav1866 in a post-hydrolytic (ADP-bound) state (30).
Identification of Regions in the Map Unique to CFTR—Sev-
eral areas of density in theCFTRmapwere not accounted for by
the Sav1866 model (i.e. they lay 5 Å from any Sav1866 atom).
Such additional (surplus) regions of the map could represent
CFTR domains not present in Sav1866 (7, 36–38), additional
bound molecules such as detergent (dodecyl maltoside), or
noise in the map. In order to discriminate between significant
differences versus noise, we focused our attention on regions
that were 1 above the mean density level and occupied the
same position (relative to the Sav1866models) in both layers of
the map, as shown in Fig. 4.
A disk- or “lozenge”-shaped surplus density that sits close to
the center of the transmembrane region and at a point corre-
sponding to a constriction of the central cavity in Sav1866 is
shown in Fig. 4, a–d. The density is closest to transmembrane
helices 3 and 6 in the fitted Sav1866 models (corresponding to
helices 3, 6, 9, and 12 in CFTR). Stereo views of the region of
interest are included in supplemental Fig. 3. Homology models
for CFTR (43–45) based on the outward facing Sav1866 struc-
ture (30, 43, 45) or the inward facing MsbA structure (45, 46)
predict residues lying close to the lozenge-shaped density.
Some of these residues have been proposed to be highly signif-
icant for channel gating on the basis of mutagenesis and cross-
linking experiments (see Table 2). Residues (Arg-352, Arg-347,
Asp-993, and Thr-1134) are predicted to be facing toward the
lozenge-shaped density in the outward facing models (43, 45).
In contrast, residue Ile-1139 faces toward the lozenge-shaped
density in only one model (43), whereas Met-1137 and Met-
1140 do so in the othermodel (45). It is also conceivable that the
lozenge-shaped density could represent tightly bound deter-
gent. Detergents have been shown to be transported substrates
for ABC efflux transporters (47).
A second region of interestwas identified in both layers of the
map distributed around the surface of a Sav1866 NBD and its
extended link to TM helix 6 (Fig. 4, e and f). This density has
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nm-diameter nanogold spheres labeling the regulatory region
co-localize to this region (8). By comparison with a CFTR con-
struct lacking NBD2, NBD2 was associated with this density
and gold label (8). Hence, this region of density maps to an area
previously associated with the regulatory region. Stereo views
of the region of interest can be obtained in supplemental Fig. 3.
A third region of interest was close to the C termini of the
Sav1866 NBDs (Fig. 4f). It seems plausible that this additional
density could be due to the NBD1 extension into the regulatory
region or perhaps due to the C-terminal extension of 40 res-
idues after NBD2 in CFTR. The former region is partly resolved
in crystallographic studies of CFTR NBD1 (48, 49). See supple-
mental Fig. 3 for a stereo view of the region of interest.
Identification of Disordered Regions of CFTR—In a separate
approach to interpret the results, we noted which parts of the
Sav1866 models occupied unexpectedly low density regions of
the map. Such “absent” regions could represent disordered or
dislocated regions in CFTR versus Sav1866. Significance was
assigned if the same regions appeared in both of the models
fitted to the upper and lower layers within themap (Fig. 5). The
free N and C termini of proteins are frequently found to be
disordered, and four regions of the Sav1866models occupy low
density in the CFTR map that probably correspond to the ter-
mini of CFTR. Regions 1 and 2 in Fig. 5 correspond to the N
termini of the two Sav1866models, and region 2 extends partly
up the first TM helix. Region 3a corresponds to the extreme C
terminus of Sav1866, whereas region 3b represents the penul-
timate NBD helix (NBD helix 8 in Sav1866). CFTR NBD1
regions C-terminal of the equivalent helix display large confor-
mational flexibility (48).
Region 4 in Fig. 5 is the cytoplasmic side of TM helix 5 and
intracytoplasmic loop 2 in one of the Sav1866 monomers. In
homology models of CFTR, this corresponds to the crossover
helices and the corresponding intracytoplasmic loop that docks
into the opposingNBD. This leads us to postulate that the cyto-
plasmic side of TM helix 11 (or 5) is a potential portal into the
cytoplasm because this region appears to be missing in the
CFTR map. Such a hypothesis is reinforced by evidence for
the crucial role of ICL4, Phe-508, and linking TM11 and TM10
helices in CFTR for communication of ATP-binding effects in
theNBDs to opening of the channel. This hypothesis could also
imply that the conformational fragility of CFTR, its Achilles
heel for maturation and escape from the endoplasmic reticu-
lum, could be an essential aspect of its channel function.
Region 5 in Fig. 5 corresponds to a surface helix in Sav1866
(residues 440–449), which, inCFTRNBD1 (residues 512–521), is
immediately downstreamof Phe-508, crucial for CFTR folding (1,
49). This helical region has also been associated with modulation
of CK2 subunit protein kinase activity (50). Arg-516 in this helix
is one of four arginine residues in CFTR that (when mutated to
lysine) rescue the F508del phenotype (51). In CFTR NBD2, this
region would correspond to residues 1311–1320.
CONCLUSIONS
The interpretation of the experimental CFTR map here has
relied on higher resolution data from a homologous ABC
exporter, Sav1866, which has been the basis of homology mod-
els for CFTR as well as other eukaryotic ABC transporters. These
homologymodels have begun to be tested experimentally (25, 43,
45, 52, 53), which should allowmore insight into their application
FIGURE 5. Sav1866 regions occupying low density regions in the CFTR map; models fitted to the upper (left) and lower (right) layers of the map, colored
according to the average map density level for the residue atoms. Red, residues located in the map where density is 1 above the mean. White, close to
the mean density level. Blue, below the mean density level. “Missing” regions in low density areas of the map, in both upper and lower layers, are indicated as
follows. 1 and 2, N termini; 3a, C termini; 3b, penultimate C-terminal helix in one NBD; 4, cytoplasmic side of TM5 and connecting ICL2; 5, N-end of short
surface-exposed NBD helix (residues 440 – 449). The tilted plane (right) highlights the area proposed to be distorted by contact with the carbon support film and
the orientation of the carbon film (crystal ab plane) with respect to the corresponding Sav1866 molecule.
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to a relatively dynamicprotein, such asCFTR. Sav1866, alongwith
all other ABC transporters, lacks the channel-regulating region of
CFTR as well as its channel properties. Similarly, no homology
models show a route for a channel through the protein or the
location of a channel gate. In this study, we provide structural
insights into these special aspects of CFTR.
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